Skip to main content
. 2022 Apr 18;14(8):2037. doi: 10.3390/cancers14082037

Figure 1.

Figure 1

Ron Activation: (1) Classical activation via MSP ligand binding induces dimerization and activation. (2) Ron overexpression facilitates ligand independent activation via homodimerization. (3) Heterodimerization with homolog RTKs including MET. (4) Alternative RON isoforms capable of constitutive activation. (5) Point mutation RON isoforms capable of constitutive phosphorylation.